Literature DB >> 7672544

Malignant esophageal strictures: staging accuracy of endoscopic ultrasonography.

M F Catalano1, J Van Dam, M V Sivak.   

Abstract

The prognosis for patients with carcinoma of the esophagus remains poor despite aggressive combination therapies and radical surgical resections. Accuracy of staging esophageal carcinoma by endoscopic ultrasonography is unmatched by that of any other modality. Of patients with esophageal carcinoma, 20% to 36% present with high-grade malignant strictures that preclude passage of the echoendoscope. Aggressive wire-guided dilation followed by complete endoscopic ultrasonographic assessment or endosonography limited to the proximal aspect of the stricture has been used in staging these patients. Of 204 patients with esophageal carcinoma, 51 (25%) presented with high-grade malignant strictures, defined as stenosis precluding passage of the echoendoscope without prior dilation. Thirty-nine of the 51 patients were treated by esophageal resection. Twenty-one of these patients underwent preoperative staging using wire-guided dilation followed by endoscopic ultrasonography, whereas 18 underwent limited endosonographic staging. Correct preoperative assessment of depth of tumor invasion (T stage) was obtained in 33% (7 of 21) of the former group and 28% (5 of 18) of the latter group. Advanced tumor stage (stage III or IV) was present in 90% (35 of 39) of patients presenting with high-grade strictures, indicating a poor prognosis for those patients. The current study demonstrates that (1) approximately 25% of all patients with esophageal carcinoma present with high-grade stricutres that preclude passage of the echoendoscope without prior dilation, (2) the majority of patients with high-grade malignant strictures present with advanced disease (stage III or IV), and (3) because of the low accuracy of endoscopic ultrasonography in staging high-grade strictures, the need to subject such patients to invasive staging studies is questionable.

Entities:  

Mesh:

Year:  1995        PMID: 7672544     DOI: 10.1016/s0016-5107(95)70186-9

Source DB:  PubMed          Journal:  Gastrointest Endosc        ISSN: 0016-5107            Impact factor:   9.427


  14 in total

1.  Through-the-scope balloon dilation for endoscopic ultrasound staging of stenosing esophageal cancer.

Authors:  Brian C Jacobson; Vanessa M Shami; Douglas O Faigel; Alberto Larghi; Michel Kahaleh; Charles Dye; Marcos Pedrosa; Irving Waxman
Journal:  Dig Dis Sci       Date:  2007-03       Impact factor: 3.199

Review 2.  Accuracy of endoscopic ultrasound in esophageal cancer staging.

Authors:  Timothy Krill; Michelle Baliss; Russel Roark; Michael Sydor; Ronald Samuel; Jenine Zaibaq; Praveen Guturu; Sreeram Parupudi
Journal:  J Thorac Dis       Date:  2019-08       Impact factor: 2.895

3.  Predicting what can go wrong at endoscopic ultrasound: a large series experience.

Authors:  Evangelos Kalaitzakis; Konstantinos Varytimiadis; John Meenan
Journal:  Frontline Gastroenterol       Date:  2010-11-20

4.  Preoperative assessment of tumor location and station-specific lymph node status in patients with adenocarcinoma of the gastroesophageal junction.

Authors:  Brechtje A Grotenhuis; Bas P L Wijnhoven; Jan Werner Poley; John J Hermans; Katharina Biermann; Manon C W Spaander; Marco J Bruno; Hugo W Tilanus; J Jan B van Lanschot
Journal:  World J Surg       Date:  2013-01       Impact factor: 3.352

5.  Endoscopic ultrasound in the staging of tumours of the oesophagus and gastro-oesophageal junction.

Authors:  D G Richards; T H Brown; J M Manson
Journal:  Ann R Coll Surg Engl       Date:  2000-09       Impact factor: 1.891

6.  Endoscopic ultrasound with conventional probe and miniprobe in preoperative staging of esophageal cancer.

Authors:  Rudolf Mennigen; Dirk Tuebergen; Gabriele Koehler; Cristina Sauerland; Norbert Senninger; Matthias Bruewer
Journal:  J Gastrointest Surg       Date:  2007-09-06       Impact factor: 3.452

7.  Miniprobe endoscopic ultrasound accurately stages esophageal cancer and guides therapeutic decisions in the era of neoadjuvant therapy: results of a multicenter cohort analysis.

Authors:  Tobias Meister; Hauke Sebastian Heinzow; Regina Osterkamp; Till Wehrmann; Torsten Kucharzik; Wolfram Domschke; Dirk Domagk; Hans Seifert
Journal:  Surg Endosc       Date:  2013-02-13       Impact factor: 4.584

8.  The preferred choice for radial endosonographic staging of esophageal cancer: standard echoendoscope or nonoptic esophagoprobe?

Authors:  C Vu; S Tsang; L Doig; J Meenan
Journal:  Surg Endosc       Date:  2007-03-07       Impact factor: 4.584

9.  Prognostic role of initial pan-endoscopic tumor length at diagnosis in operable esophageal squamous cell carcinoma undergoing esophagectomy with or without neoadjuvant concurrent chemoradiotherapy.

Authors:  Chen-Sung Lin; Chao-Yu Liu; Chih-Tao Cheng; Yu-Chen Tsai; Lun-Wei Chiou; Ming-Yuan Lee; Chia-Chuan Liu; Chih-Hsun Shih
Journal:  J Thorac Dis       Date:  2017-09       Impact factor: 2.895

10.  Dilation of malignant strictures in endoscopic ultrasound staging of esophageal cancer and metastatic spread of disease.

Authors:  Shawn M Hancock; Deepak V Gopal; Terrence J Frick; Patrick R Pfau
Journal:  Diagn Ther Endosc       Date:  2011-11-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.